Atlas Trials

Metformin With Neoadjuvant Chemoradiation to Improve Pathologic Responses in Rectal Cancer

Clinical trial NCT03053544 · COMPLETED

Trial details

NCT number
NCT03053544
Sponsor
Sunnybrook Health Sciences Centre
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal Neoplasm Carcinoma in Situ Adenocarcinoma
Start date
2016-12-08
Primary completion
2019-06-26
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.